Functional Attributes in Pathways

• Substrates : 100 entries in CutDB for S01.217 Ext
  • Aldo-keto reductase family 7, member a2
  • Arylalkylamine n-acetyltransferase
  • coagulation factor II (thrombin) receptor-like 1 precursor
  • coagulation factor II (thrombin) receptor-like 2 precursor
  • coagulation factor II (thrombin) receptor-like 3 precursor
  • coagulation factor II receptor precursor
  • Coagulation factor ii receptor precursor
  • coagulation factor IX preproprotein
  • coagulation factor V precursor
  • Coagulation factor V precursor
  • coagulation factor VII
  • coagulation factor VIII isoform a precursor
  • coagulation factor XIII A1 subunit precursor
  • Complement component C9 precursor
  • Fibrinogen alpha/alpha-E chain precursor
  • fibrinogen, alpha polypeptide
  • fibrinogen, alpha polypeptide isoform alpha-E preproprotein
  • fibrinogen, beta chain preproprotein
  • Glycoprotein v (platelet)
  • heat shock 70kD protein binding protein
  • Hgf activator preproprotein
  • HGF activator preproprotein
  • Insulin-like growth factor binding protein 3 isoform b precursor
  • Insulin-like growth factor binding protein 5
  • microtubule-associated protein tau isoform 1
  • microtubule-associated protein tau isoform 2
  • microtubule-associated protein tau isoform 3
  • microtubule-associated protein tau isoform 4
  • microtubule-associated protein tau isoform 5
  • microtubule-associated protein tau isoform 6
  • nidogen 1
  • Plasma carboxypeptidase b2 isoform a preproprotein
  • platelet coagulation factor XI precursor
  • protein C precursor (Homo sapiens)
  • Protein s (alpha)
  • Proteinase-activated receptor 4 precursor (PAR-4)
  • prothrombin (Bos taurus)
  • prothrombin (Homo sapiens)
  • Prothrombin precursor
  • Serine (or cysteine) proteinase inhibitor, clade c (antithrombin), member 1
  • syndecan 4 precursor
  • Thrombopoietin isoform 1 precursor
  • thrombopoietin precursor
  • urokinase plasminogen activator preproprotein
  • Vitamin K-dependent protein S precursor
• Substrate Specificity -- Under development
• Inhibitors -- Under development
• Pathways -- Under development